Chroman derivatives
US8044097B2 · kind B2 · utility
33Cited by
74References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2009 |
| Grant date | Oct 25, 2011 |
| Priority date | — |
| Expiry date | Oct 24, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel chroman derivatives, stereoisomers and pharmaceutically acceptable salts of Formula Iwherein the substituents are as defined in the specification. They are useful in the treatment of disorders mediated by lipoxygenase, such as immune diseases, respiratory diseases and cardiovascular diseases, as well as in the treatment of neurodegenerative disorders and/or mitochondria) disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.